학술논문
Abrocitinib efficacy and safety in patients with moderate-to-severe atopic dermatitis: Results from phase 3 studies, including the long-term extension JADE EXTEND study
Document Type
Article
Author
Source
In: Journal of the European Academy of Dermatology and Venereology . (Journal of the European Academy of Dermatology and Venereology, October 2023, 37(10):2056-2066)
Subject
Language
English
ISSN
14683083
09269959
09269959